Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Relenza Litigation Settlement

GlaxoSmithKline settled a lawsuit filed by Australian biotech company Biota Holdings Limited over the commercialization of the flu drug Relenza (known generically as zanamivir). Under the terms of the settlement, GSK admits no liability but will make a payment of A$20 million (USD$19.5 million) to Biota. Biota developed Relenza and licensed it to GSK in 2000 which brought it to market, but it never became a top seller. Biota filed suit in May 2004, accusing GSK of failing to properly promote Relenza. Both companies will continue to market Relenza as per the initial agreement, which remains unchanged by the settlement.

Misconduct Type
Poor Contract Performance
Enforcement Agency
Non-Governmental
Contracting Party
Non-Governmental
Court Type
Civil
Disposition
Settlement
Date of Announcement
7/21/2008
Contractors Involved Penalty
Total
GlaxoSmithKline $19,500,000
Further Information Released
Biota Press Release 8/15/2008
GlaxoSmithKline Press Release 8/15/2008

Federal Contractor Misconduct Database